Table 4.
Level of Adjustment | Decreased Weight/Waist |
Weight Increase/ Waist Decrease HR(95%CI) |
Weight Decrease/ Waist Increase HR(95%CI) |
Increased Weight/Waist HR(95%CI) |
Overall Type 3 P-value |
---|---|---|---|---|---|
Primary CVD Outcome* | |||||
Model 1 | REF | 0.64 (0.28, 1.44) | 1.31 (0.94, 1.82) | 1.41 (0.86, 2.30) | 0.1386 |
Model 2 | REF | 0.75 (0.33, 1.70) | 1.55 (1.11, 2.17)* | 1.76 (1.07, 2.89)* | 0.0096 |
Model 3 | REF | 0.58 (0.24, 1.41) | 1.48 (1.05, 2.09)* | 1.32 (0.77, 2.25) | 0.0609 |
Secondary CVD Outcome** | |||||
Model 1 | REF | 0.95 (0.54, 1.66) | 1.20 (0.90, 1.59) | 1.70 (1.16, 2.50)* | 0.0370 |
Model 2 | REF | 1.13 (0.64, 1.97) | 1.42 (1.07, 1.89)* | 2.17 (1.47, 3.20)* | 0.0002 |
Model 3 | REF | 0.92 (0.50, 1.69) | 1.43 (1.07, 1.92)* | 1.80 (1.19, 2.74)* | 0.0056 |
Note: indicates HR is statistically significantly different from reference group; Model 1 is adjusted for clinical site only; Model 2 is adjusted for sex, age, race, and clinical site; Model 3 is adjusted for sex, age, race, clinical site, cardiovascular disease history, insulin use, diabetes duration, weight, systolic blood pressure, diastolic blood pressure, LDL cholesterol, and smoking status